Microsoft (NASDAQ:MSFT) Discovers ChatGPT is No Substitute for Cancer Doctors
ChatGPT, however, took its own path in roughly one out of every three cases. While ChatGPT did at least sometimes agree with the NCCN in 98% of cases, ...